Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 204.39M | 196.46M | 262.66M | 224.62M | 176.94M | 155.90M |
Gross Profit | 63.15M | 59.97M | 83.69M | 71.70M | 58.83M | 49.67M |
EBITDA | -1.08M | 4.72M | 28.65M | 19.40M | 7.92M | 1.73M |
Net Income | -2.34M | 61.00K | 22.33M | 17.93M | 1.66M | -1.84M |
Balance Sheet | ||||||
Total Assets | 189.81M | 192.44M | 198.05M | 179.82M | 156.11M | 150.72M |
Cash, Cash Equivalents and Short-Term Investments | 36.67M | 24.26M | 24.98M | 40.49M | 43.32M | 46.53M |
Total Debt | 2.04M | 2.76M | 2.46M | 3.02M | 2.42M | 3.43M |
Total Liabilities | 36.91M | 34.49M | 38.73M | 43.97M | 34.55M | 32.06M |
Stockholders Equity | 152.90M | 157.95M | 159.32M | 135.85M | 121.56M | 118.66M |
Cash Flow | ||||||
Free Cash Flow | 14.74M | 2.48M | -15.58M | -1.21M | -1.80M | 147.00K |
Operating Cash Flow | 17.72M | 6.52M | -8.20M | 1.91M | 832.00K | 1.92M |
Investing Cash Flow | 4.02M | -4.04M | -2.18M | -8.12M | 13.37M | -9.78M |
Financing Cash Flow | -3.00M | -2.90M | 389.00K | -352.00K | -3.01M | -3.21M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
64 Neutral | $139.08M | 303.10 | -1.50% | 2.45% | -1.69% | -185.91% | |
58 Neutral | $78.82M | ― | -18.75% | ― | -18.62% | -112.68% | |
56 Neutral | $3.18B | 5.02 | -5.68% | 5.66% | 8.05% | -41.83% | |
54 Neutral | $250.71M | ― | -112.75% | ― | 28.16% | 74.88% | |
54 Neutral | $129.55M | ― | -24.86% | ― | 2.59% | -48.02% | |
53 Neutral | $393.90M | ― | -40.61% | ― | -18.53% | 46.30% | |
51 Neutral | $352.62M | ― | -11.90% | 5.67% | -6.16% | -59.41% |
On January 24, 2025, Richardson Electronics announced the sale of its International Medical Equipment and Service business assets to DirectMed Imaging for $8.2 million. This strategic move aligns with Richardson’s priorities to support its growing Green Energy Solutions business and involves a 10-year supply agreement with DirectMed, simplifying Richardson’s operations and focusing on higher-growth markets.